ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,513.94
0.10%
Dow Jones
43,487.83
0.78%
Gold vs US Dollar
2,709.905
0.51%
Brent Oil
79.75
-0.58%
Bitcoin
107,610.39
4.36%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Eagle Capital Growth Fund Inc (GRF) Share Price

GRF Eagle Capital Growth Fund Inc

9.6786
-0.0964 (-0.99%)
17 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Eagle Capital Growth Fund Inc AMEX:GRF American Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0964 -0.99 9.6786 0.00 0.00 9.7335 9.65 9.65 1,536 21:00:07   
*quotes are delayed by at least 20 minutes
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Unit Inv Tr, Closed-end Mgmt 736k 4.61M 1.1623 8.33 38.79M
 Type  Size  Price  Time  Units 
 13 100 9.6786 01:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore GRF News
14/01/202511:00GLOBEGrifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
26/12/202418:40EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
05/12/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
19/11/202413:00GLOBEGigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
18/11/202421:00BWEagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
29/10/202412:00GLOBEGrifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
22/10/202412:00GLOBEGrifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Period
Draw mode
Data Downloads for GRF

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Eagle Capital Growth Fund Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads